Follow-Up of Bone Mineral Density Changes in de novo Kidney Transplant Recipients Treated with Two Doses of the Receptor Activator of Nuclear Factor κB Ligand Inhibitor Denosumab

• मुख्य लेखकों: Claudia Kobel (लेखक), Diana Frey (लेखक), Nicole Graf (लेखक), Rudolf P. Wüthrich (लेखक), Marco Bonani (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Karger Publishers, 2019-10-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Background: Studies in women with post-menopausal osteoporosis have shown that discontinuation of treatment with denosumab leads to an increased risk of vertebral fractures because of rebound bone turnover and rapid loss of bone mineral density (BMD). Methods: In a post hoc analysis of the Prolia fo...